Advances in the development and use of human tissue-based techniques for drug toxicity testing

Bibliography

• Arrowsmith J. Trial watch: phase III and submission failures: 2007 – 2010. Nat Rev Drug Discov 2011;10(2):87
   PubMed Web of Science ®Google Scholar
• Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004;3(8):711-15
   PubMed Web of Science ®Google Scholar
• Available from: www.imi-safe-t.eu [Last accessed 3 January 2013]
   Google Scholar
• Sun H, Xia M, Austin CP, et al. Paradigm shift in toxicity testing and modeling. AAPS J 2012;14(3):473-80
   PubMed Web of Science ®Google Scholar
• Goldman M, Compton C, Mittleman BB. Public-private partnerships as driving forces in the quest for innovative medicines. Clin Transl Med 2013;2(1):2
   PubMedGoogle Scholar
• van Meer PJ, Kooijman M, Gispen-de Wied CC, et al. The ability of animal studies to detect serious post marketing adverse events is limited. Regul Toxicol Pharmacol 2012;64(3):345-9
   PubMed Web of Science ®Google Scholar
• Seok J, Warren HS, Cuenka AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013;110(9):3507-12
   PubMed Web of Science ®Google Scholar
• Abraham T, Kayra D, McManus B, Scott A. Quantitative assessment of forward and backward second harmonic three dimensional images of collagen Type I matrix remodeling in a stimulated cellular environment. J Struct Biol 2012;180(1):17-25
   PubMed Web of Science ®Google Scholar
• Pagliari S, Vilela-Silva AC, Forte G, et al. Cooperation of biological and mechanical signals in cardiac progenitor cell differentiation. Adv Mater 2011;23(4):514-18
   PubMed Web of Science ®Google Scholar
• Lee KS, Zhou W, Scott-McKean JJ, et al. Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection. PLoS One 2012;7(12):e53010
   PubMed Web of Science ®Google Scholar
• Kinnear C, Chang WY, Khattak S, et al. Modeling and Rescue of the Vascular Phenotype of Williams-Beuren Syndrome in Patient Induced Pluripotent Stem Cells. Stem Cells Transl Med 2012; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Astashkina A, Mann B, Grainger DW. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacol Ther 2012;134(1):82-106
   PubMed Web of Science ®Google Scholar
• Lee WM, Squires RH Jr, Nyberg SL, et al. Acute liver failure: summary of a workshop. Hepatology 2008;47(4):1401-15
   PubMed Web of Science ®Google Scholar
• Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005;4(6):489-99
   PubMed Web of Science ®Google Scholar
• Jaeschke H, et al. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65(2):166-76
   PubMed Web of Science ®Google Scholar
• Dykens J, Will Y. Drug-induced mitochondrial dysfunction. John Wiley and Sons, Hoboken, New Jersey; 2008
   Google Scholar
• Xu JJ, et al. Predicting Drug-Induced Hepatotoxicity. In: Urban BFAL, editor. In vitro, in silico and in vivo approaches, in hit and lead profiling. WILEY-VCH, Weinheim, Germany; 2009. p. 345-85
   Google Scholar
• LeCluyse EL, Witek RP, Andersen ME, et al. Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol 2012;42(6):501-48
   PubMed Web of Science ®Google Scholar
• Mazzoleni G, Steimberg N. New models for the in vitro study of liver toxicity: 3D culture systems and the role of bioreactors. Chapter. In: Tyshenko MG, editor. The continuum of health risk assessments. ISBN 980-953-307-582-7: InTech (Open Access Publishing), 2012
   Google Scholar
• Meng Q. Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 2010;6(6):733-46
   PubMed Web of Science ®Google Scholar
• Curtis CG, Bilyard K, Stephenson H. Ex Vivo Metrics™, a preclinical tool in new drug development. J Transl Med 2008;6:5
   PubMed Web of Science ®Google Scholar
• Brandon EFA, Raap CD, Meijerman I, et al. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol Appl Pharmacol 2003;189:233-46
   PubMed Web of Science ®Google Scholar
• Olinga P, Groothuis GMM. Use of human tissue slices in drug targeting research. In: Molema G, Meijer DKF, editors. Drugtargeting: organ specific strategies. Wiley-VCH, Weinheim; 2001. p. 309-31
   Google Scholar
• Van de Bovenkamp M, Groothuis GM, Meijer DK, Olinga P. Liver fibrosis in vitro: Cell culture models and precision-cut liver slices. Toxicol In Vitro 2007;21:545-57
   PubMed Web of Science ®Google Scholar
• Van de Bovenkamp M, Groothuis GM, Meijer DK, et al. Human liver slices as an in vitro model to study toxicity-induced hepatic stellate cell activation in a multicellular milieu. Chem Biol Interact 2006;162:62-9
   PubMed Web of Science ®Google Scholar
• Elferink MGL, Olinga P, van Leeuwen EM, et al. Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol 2011;253:57-69
   PubMed Web of Science ®Google Scholar
• Khan AA, Chow CCY, Porte RJ, et al. The role of lithocholic acid in the regulation of bile acid detoxication, synthesis, and transport proteins in rat and human intestine and liver slices. Toxicol In Vitro 2011;25(1):80-90
   PubMed Web of Science ®Google Scholar
• Elferink MGL, Olinga P, Draaisma AL, et al. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. J Physiol Gastrointest Liver Physiol 2004;287:G1008-16
   PubMed Web of Science ®Google Scholar
• Plazar J, Hreljac I, Pirih P, et al. Detection of xenobiotic-induced DNA damage by the comet assay applied to human and rat precision-cut liver slices. Toxicol In Vitro 2007;21(6):1134-42
   PubMed Web of Science ®Google Scholar
• Hadi M, Dragovic S, van Swelm R, et al. AMAP, the alleged non-toxic isomer of acetaminophen, is toxic in rat and human liver. Arch Toxicol 2012; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Vinci B, Duret C, Klieber S, et al. Modular bioreactor for primary human hepatocyte culture: medium flow stimulates expression and activity of detoxification genes. Biotechnol J 2011;6:554-64
   PubMed Web of Science ®Google Scholar
• Wang Y, Cui CB, Yamauchi M, et al. Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology 2011;53:293-305
   PubMed Web of Science ®Google Scholar
• Swift B, Pfeifer ND, Brouwer KL. Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 2010;42(3):446-71
   PubMed Web of Science ®Google Scholar
• McIntosh MB, Corner SM, Amiot BP, et al. Engineering analysis and development of the spheroid reservoir bioartificial liver. Conf Proc IEEE Eng Med Biol Soc 2009;2009:5985-8
   PubMedGoogle Scholar
• Tostões RM, Leite SB, Miranda JP, et al. Perfusion of 3D encapsulated hepatocytes--a synergistic effect enhancing long-term functionality in bioreactors. Biotechnol Bioeng 2011;108(1):41-9
   PubMed Web of Science ®Google Scholar
• Novik E, Maguire TJ, Chao P, et al. A microfluidic hepatic coculture platform for cell-based drug metabolism studies. Biochem Pharmacol 2010;79(7):1036-44
   PubMed Web of Science ®Google Scholar
• Khetani SR, Bhatia SN. Microscale culture of human liver cells for drug development. Nature Biotechnology 2008;26:120-6
   PubMed Web of Science ®Google Scholar
• WeiWei Wang W, Khetani SR, Krzyzewski S, et al. Assessment of a micropatterned hepatocyte coculture system to generate major human excretory and circulating drug metabolites. Drug Metab Dispos 2010;38(10):900-1905
   Web of Science ®Google Scholar
• Goyal RK, Hirano I. The enteric nervous system. New Engl J Med 1996;334:1106-15
   PubMed Web of Science ®Google Scholar
• Wei Y, Neves LA, Franklin T, et al. Vascular perfused segments of human intestine as a tool for drug absorption. Drug Metab Dispos 2009;37(4):731-6
   PubMed Web of Science ®Google Scholar
• Broad J, Mukherjee S, Samadi M, et al. Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists. Br J Pharmacol 2012;167(4):763-74
   PubMed Web of Science ®Google Scholar
• van de Kerkhof EG, Ungell AL, Sjoberg AK, et al. Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with ussing chamber preparations. Drug Metab Dispos 2006;34:1893-902
   PubMed Web of Science ®Google Scholar
• Li M, Si LQ, Pan HP, et al. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: Assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Int J Pharm 2011;403:7-45
   Web of Science ®Google Scholar
• Alam MA, Al-Jenoobi FI, Al-Mohizea AM. Everted gut sac model as a tool in pharmaceutical research: limitations and applications. J Pharm Pharmacol 2012;64(3):326-36
   PubMed Web of Science ®Google Scholar
• Randall KJ, Turton J, Foster JR. Explant culture of gastrointestinal tissue: a review of methods and applications. Cell Biol Toxicol 2011;27:267-84
   PubMed Web of Science ®Google Scholar
• Groothuis GMM, de Graaf IAM. Precision-cut intestinal slices as in vitro tool for studies on drug metabolism. Curr Drug Metabol 2013;14(8):112-19
   PubMed Web of Science ®Google Scholar
• Kim HJ, Huh D, Hamilton G, et al. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 2012;12(12):2165-74
   PubMed Web of Science ®Google Scholar
• Gharib SA, Nguyen E, Altemeier WA, et al. Of mice and men: comparative proteomics of bronchoalveolar fluid. Eur Respir J 201;35(6):1388-95
   Google Scholar
• Frank JA, Briot R, Lee JW, et al. Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am J Physiol Lung Cell Mol Physiol 2007;293(1):L52-9
   PubMed Web of Science ®Google Scholar
• Cypel M, Yeung JC, Hirayama S, et al. Technique for prolonged normothermic ex vivo lung perfusion. J Heart Lung Transplant 2008;27:1319-25
   PubMed Web of Science ®Google Scholar
• Cypel M, Rubacha M, Yeung J, et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am J Transplant 2009;9:2262-9
   PubMed Web of Science ®Google Scholar
• Steen S, Ingemansson R, Eriksson L, et al. First human transplantation of a nonacceptable donor lung after reconditioning ex vivo. Ann Thorac Surg 2007;83(6):2191-4
   PubMed Web of Science ®Google Scholar
• Switalla S, Lauenstein L, Prenzler F, et al. Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices. Toxicol Appl Pharmacol 2010(246):107-15
   PubMed Web of Science ®Google Scholar
• Sewald K, Braun A. Assessment of immunotoxicity using precision-cut tissue slices. Xenobiotica 2013;43(1):84-97
   PubMed Web of Science ®Google Scholar
• BéruBé K, Prytherch Z, Job C, et al. Human primary bronchial lung cell constructs: the new respiratory models. Toxicology 2010;278(3):311-18
   PubMed Web of Science ®Google Scholar
• Huang S, Wiszniewski L, Constant S. The use of in vitro 3d cell models in drug development for respiratory diseases. Chapter 8. In: Kapetanovic IM, editor. Drug discovery and development- present and future. ISBN 978-953-307-615-7: InTech (Open Access Publishing), 2011. p. 169-90
   Google Scholar
• Sexton K, Balharry D, Brennan P, et al. Proteomic profiling of human respiratory epithelia by iTRAQ reveals biomarkers of exposure and harm by tobacco smoke components. Biomarkers 2011;16(7):567-76
   PubMed Web of Science ®Google Scholar
• Richter PA, Li AP, Polzin G, Roy SK. Cytotoxicity of eight cigarette smoke condensates in three test systems: comparisons between assays and condensates. Regul Toxicol Pharmacol 2010;58(3):428-36
   PubMed Web of Science ®Google Scholar
• Li AP. The Use of the Integrated Discrete Multiple Organ Coculture (IdMOC®) system for the evaluation of multiple organ toxicity. ATLA 2009;37:377-85
   Google Scholar
• Huh D, Matthews BD, Mammoto A, et al. Reconstituting organ-level lung functions on a chip. Science 2010;328(5986):1662-8
   PubMed Web of Science ®Google Scholar
• Huh D, Leslie DC, Matthews BD, et al. A human disease model of drug toxicity–induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med 2012;4:159ra147
   PubMed Web of Science ®Google Scholar
• Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use. U. S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research February 28, 1997
   Google Scholar
• Stebbings R, Findlay L, Edwards C, et al. “Cytokine storm” in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics. J Immunol 2007;179:3325-31
   PubMed Web of Science ®Google Scholar
• Cupedo T, Stroock A, Coles M. Application of tissue engineering to the immune system: development of artifical lymph nodes. Front Immun 2012;3:343
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Kato K, Watanabe T. Synthesis of functional artificial lymphoid tissues. Discov Med 2011;12:351-62
   PubMed Web of Science ®Google Scholar
• Higbee RG, Byers AM, Dhir V, et al. An immunologic model for rapid vaccine assessment -- a clinical trial in a test tube. Altern Lab Anim 2009;37(Suppl 1):19-27
   PubMed Web of Science ®Google Scholar
• Caspi O, Itzhaki I, Kehat I, et al. In Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived Cardiomyocytes. Stem Cells Dev 2009;18(1):161-72
   PubMed Web of Science ®Google Scholar
• Barth AS, Zhang Y, Li T, et al. Functional impairment of human resident cardiac stem cells by the cardiotoxic antineoplastic agent trastuzumab. Stem Cells Transl Med 2012;1(4):289-97
   PubMed Web of Science ®Google Scholar
• Fedele C, Riccio G, Coppola C, et al. Comparison of preclinical cardiotoxic effects of different ErbB2 inhibitors. Breast Cancer Res Treat 2012;133(2):511-21
   PubMed Web of Science ®Google Scholar
• Franchini JL, Propst JT, Comer GR, et al. Novel tissue engineered tubular heart tissue for in vitro pharmaceutical toxicity testing. Microsc Microanal 2007;13(4):267-71
   PubMed Web of Science ®Google Scholar
• Xu T, Baicu C, Aho M, et al. Fabrication and characterization of bio-engineered cardiac pseudo tissues. Biofabrication 2009;1(3):035001
   PubMed Web of Science ®Google Scholar
• Hill AJ, Laske TG, Coles JA Jr, et al. In vitro studies of human hearts. Ann Thorac Surg 2005;79(1):168-77
   PubMed Web of Science ®Google Scholar
• Fenichel RR, Malik M, Antzelevitch C, et al. Drug-Induced Torsade de Pointes and Implications for Drug Development. J Cardiovasc Electrophysiol 2004;15(4):475-95
   PubMed Web of Science ®Google Scholar
• Zwi L, Caspi O, Arbel G, et al. Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells. Circulation 2009;120:1513-23
   PubMed Web of Science ®Google Scholar
• Itzhaki I, Maizels L, Huber I, et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011;471(7337):225-9
   PubMed Web of Science ®Google Scholar
• Moretti A, Bellin M, Welling A, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. Engl J Med 2010;363(15):1397-409
   PubMed Web of Science ®Google Scholar
• Nguemo F, Šarić T, Pfannkuche K, et al. In vitro model for assessing arrhythmogenic properties of drugs based on high-resolution impedance measurements. Cell Physiol Biochem 2012;29(5-6):819-32
   PubMed Web of Science ®Google Scholar
• Cerignoli F, Charlot D, Whittaker R, et al. High throughput measurement of Ca(2+) dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry. J Pharmacol Toxicol Methods 2012;66(3):246-56
   PubMed Web of Science ®Google Scholar
• Moss E, Lynagh S, Smith D, et al. A novel system for the investigation of microvascular dysfunction including vascular permeability and flow-mediated dilatation in pressurised human arteries. J Pharmacol Toxicol Methods 2010;62(1):40-6
   PubMed Web of Science ®Google Scholar
• East E, Phillips JB. Tissue engineered cell culture models for nervous system research. In: Greco GN, editor. Tissue engineering research trends. 978-1-60456-264-4: Nova Science Publishers, Inc, Hauppage, New York; 2008. p. 141-60
   Google Scholar
• Root J, Wakenhut AM, Siggins H, et al. Opioid receptor characterisation of neuronally stimulated isolated human vas deferens. Naunyn Schmiedebergs Arch Pharmacol 2012;385(11):1049-52
   PubMed Web of Science ®Google Scholar
• Cunningham MO, Roopun A, Schofield IS, et al. Glissandi: transient fast electrocorticographic oscillations of steadily increasing frequency, explained by temporally increasing gap junction conductance. Epilepsia 2012;53(7):1205-14
   PubMed Web of Science ®Google Scholar
• Haidet-Phillips AM, Hester ME, Miranda CJ, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 2011;29(9):824-8
   PubMed Web of Science ®Google Scholar
• East E, Phillips JB. Engineering an integrated cellular interface in three-dimensional hydrogel cultures permits monitoring of reciprocal astrocyte and neuronal responses. Tissue Engi Part C Methods 2012;18(7):526-36
   PubMed Web of Science ®Google Scholar
• Wright KE, MacRobert AJ, Phillips JB. Inhibition of specific cellular antioxidant pathways increases the sensitivity of neurons to meta-tetrahydroxyphenyl chlorin-mediated photodynamic therapy in a 3D co-culture model. Photochem Photobiol 2012;88(6):1539-45
   PubMed Web of Science ®Google Scholar
• Teeling-Smith G. A question of balance; the benefits and risks of pharmaceutical innovation. Office of Health Economics, London, UK; 1980. p. 29
   Google Scholar
• Knobloch J, Reimann K, Klotz LO, Rüther U. Thalidomide resistance is based on the capacity of the glutathione-dependent antioxidant defense. Mol Pharm 2008;5(6):1138-44
   PubMed Web of Science ®Google Scholar
• Monaco MC, Maric D, Bandeian A, et al. Progenitor-derived oligodendrocyte culture system from human fetal brain. J Vis Exp 2012;70):4274
   PubMed Web of Science ®Google Scholar
• Balmer NV, Weng MK, Zimmer B, et al. Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome. Hum Mol Genet 2012;21(18):4104-14
   PubMed Web of Science ®Google Scholar
• Schreiber T, Gassmann K, Götz C, et al. Polybrominated diphenyl ethers induce developmental neurotoxicity in a human in vitro model: evidence for endocrine disruption. Environ Health Perspect 2010;118(4):572-8
   PubMed Web of Science ®Google Scholar
• Stiegler NV, Krug AK, Matt F, Leist M. Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures. Toxicol Sci 2011;121(1):73-87
   PubMed Web of Science ®Google Scholar
• Brieño-Enríquez MA, Reig-Viader R, Cabero L, et al. Gene expression is altered after bisphenol A exposure in human fetal oocytes in vitro. Mol Hum Reprod 2012;18(4):171-83
   PubMed Web of Science ®Google Scholar
• Brieño-Enríquez MA, Robles P, Camats-Tarruella N, et al. Human meiotic progression and recombination are affected by Bisphenol A exposure during in vitro human oocyte development. Hum Reprod 2011;26(10):2807-18
   PubMed Web of Science ®Google Scholar
• Papadimitropoulos A, Scherberich A, Güven S, et al. A 3D in vitro bone organ model using human progenitor cells. Eur Cell Mater 2011;21:445-58. discussion 458
   PubMed Web of Science ®Google Scholar
• Parker BA, Capizzi JA, Grimaldi AS, et al. Effect of statins on skeletal muscle function. Circulation 2013;127(1):96-103
   PubMed Web of Science ®Google Scholar
• Knauer MJ, Urquhart BL, Meyer zu Schwabedissen HE, et al. Human skeletal muscle drug transporters determine local exposure and toxicity of statins. Circ Res 2010;106(2):297-306
   PubMed Web of Science ®Google Scholar
• Sharples AP, Player DJ, Martin NR, et al. Modelling in vivo skeletal muscle ageing in vitro using three-dimensional bioengineered constructs. Aging Cell 2012;11(6):986-95
   PubMed Web of Science ®Google Scholar
• Hayashi K, Mori T, Abo T, et al. Two-stage bottom-up tiered approach combining several alternatives for identification of eye irritation potential of chemicals including insoluble or volatile substances. Toxicol In Vitro 2012;26(7):1199-208
   PubMed Web of Science ®Google Scholar
• Forsby A, Norman KG, El Andaloussi-Lilja J, et al. Using novel in vitro NociOcular assay based on TRPV1 channel activation for prediction of eye sting potential of baby shampoos. Toxicol Sci 2012;129(2):325-31
   PubMed Web of Science ®Google Scholar
• Paquet C, Larouche D, Bisson F, et al. Tissue engineering of skin and cornea: development of new models for in vitro studies. Ann NY Acad Sci 2010;1197:166-77
   PubMed Web of Science ®Google Scholar
• Mehling A, Eriksson T, Eltze T, et al. Non-animal test methods for predicting skin sensitization potentials. Arch Toxicol 2012;86(8):1273-95
   PubMed Web of Science ®Google Scholar
• Luebke R. Immunotoxicant screening and prioritization in the twenty-first century. Toxicol Pathol 2012;40(2):294-9
   PubMed Web of Science ®Google Scholar
• Sarmento B, Andrade F, da Silva SB, et al. Cell-based in vitro models for predicting drug permeability. Expert Opin Drug Metab Toxicol 2012;8(5):607-21
   PubMed Web of Science ®Google Scholar
• Li AP, Bode C, Sakai Y. A novel in vitro system, the integrated discrete multiple organ cell culture (IdMOC) system, for the evaluation of human drug toxicity: comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells. Chem Biol Interact 2004;150(1):129-36
   PubMed Web of Science ®Google Scholar
• Li AP. The Use of the Integrated Discrete Multiple Organ Coculture (IdMOC®) System for the Evaluation of Multiple Organ Toxicity. ATLA 37, 377–385, 2009. Regul Toxicol Pharmacol 2010;58(3):428-36
   PubMed Web of Science ®Google Scholar
• Neuži P, Giselbrecht S, Länge K, et al. Revisiting lab-on-a-chip technology for drug discovery. Nat Rev Drug Discov 2012;11(8):620-32
   PubMed Web of Science ®Google Scholar
• Clotworthy M. The application of human tissue for drug discovery and development. Expert Opin Drug Discov 2012;7(7):543-7
   PubMed Web of Science ®Google Scholar
• Toxicity Testing in the 21st Century, a Vision and a Strategy. Committee on Toxicity Testing and Assessment of Environmental Agents, National Research Council (2007). Andersen ME, Krewski D. Toxicity testing in the 21st century: bringing the vision to life. Toxicol Sci 2009;107(2):324-30
   PubMed Web of Science ®Google Scholar
• Coleman RA. Human tissue in the evaluation of safety and efficacy of new medicines: a viable alternative to animal models? ISRN Pharm 2011;2011:806789
   PubMedGoogle Scholar
• Varki NM, Strobert E, Dick EJ Jr, et al. Biomedical differences between human and nonhuman hominids: potential roles for uniquely human aspects of sialic acid biology. Annu Rev Pathol 2011;6:365-93
   PubMed Web of Science ®Google Scholar
• Johnson JI, Decker S, Zaharevitz D, et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models an early clinical trials. Br J Cancer 2001;84:1424-31
   PubMed Web of Science ®Google Scholar
• Voskoglou-Nomikos T, Pater JL, Seymour L. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res 2003;9:4227-39
   PubMed Web of Science ®Google Scholar
• Haddad TC, Yee D. Of mice and (wo)men: is this any way to test a new drug? J Clin Oncol 2008 Feb 20;26(6):830-2
   PubMed Web of Science ®Google Scholar
• Sausville EA, Burger AM. Contributions of human tumor xenografts to anticancer drug development. Cancer Res 2006 Apr 1;66(7):3351-4. discussion 3354
   PubMed Web of Science ®Google Scholar
• Available from: http://tissueforresearch.com/available-tissues.html [Accessed 4 January 2013]
   Google Scholar